AADAC | Arylacetamide deacetylase | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
AATK | Apoptosis-associated tyrosine kinase | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ADTRP | Androgen-dependent TFPI-regulating protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AKR1B10 | Aldo-keto reductase family 1, member B10 (aldose reductase) | Predicted intracellular proteins
| | | | | Tissue enhanced |
AKR1B15 | Aldo-keto reductase family 1, member B15 | Predicted intracellular proteins
| | | | | Tissue enhanced |
AKR7A3 | Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKS4B | Ankyrin repeat and sterile alpha motif domain containing 4B | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANO9 | Anoctamin 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANXA13 | Annexin A13 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AQP11 | Aquaporin 11 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ARHGDIG | Rho GDP dissociation inhibitor (GDI) gamma | Predicted intracellular proteins
| | | | | Tissue enhanced |
B3GALT5 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT8 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 | Predicted secreted proteins
| | | | | Tissue enhanced |
BAIAP2L2 | BAI1-associated protein 2-like 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
BCO1 | Beta-carotene oxygenase 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
C6orf222 | Chromosome 6 open reading frame 222 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CALML4 | Calmodulin-like 4 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CBLC | Cbl proto-oncogene C, E3 ubiquitin protein ligase | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CCK | Cholecystokinin | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCL15 | Chemokine (C-C motif) ligand 15 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDHR5 | Cadherin-related family member 5 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CTD-2510F5.6 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000464167} | Predicted intracellular proteins
| | | | | Tissue enhanced |
CTD-2545M3.6 | | Predicted intracellular proteins
| | | | | Tissue enhanced |
CYP2C18 | Cytochrome P450, family 2, subfamily C, polypeptide 18 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2C19 | Cytochrome P450, family 2, subfamily C, polypeptide 19 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2S1 | Cytochrome P450, family 2, subfamily S, polypeptide 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP3A5 | Cytochrome P450, family 3, subfamily A, polypeptide 5 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CYP4F12 | Cytochrome P450, family 4, subfamily F, polypeptide 12 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DAB1 | Dab, reelin signal transducer, homolog 1 (Drosophila) | Predicted intracellular proteins
| | | | | Tissue enhanced |
DDC | Dopa decarboxylase (aromatic L-amino acid decarboxylase) | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
DQX1 | DEAQ box RNA-dependent ATPase 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
EDN3 | Endothelin 3 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
ENTPD8 | Ectonucleoside triphosphate diphosphohydrolase 8 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EXOC3L4 | Exocyst complex component 3-like 4 | Predicted intracellular proteins
| | | | | Tissue enhanced |
FADS6 | Fatty acid desaturase 6 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FAM3B | Family with sequence similarity 3, member B | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FBP1 | Fructose-1,6-bisphosphatase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
FOLH1 | Folate hydrolase (prostate-specific membrane antigen) 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FUT2 | Fucosyltransferase 2 (secretor status included) | Blood group antigen proteins Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
GAL3ST1 | Galactose-3-O-sulfotransferase 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
GATA4 | GATA binding protein 4 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
GATA5 | GATA binding protein 5 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
GCNT1 | Glucosaminyl (N-acetyl) transferase 1, core 2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
GCNT4 | Glucosaminyl (N-acetyl) transferase 4, core 2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
GDA | Guanine deaminase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
GHRH | Growth hormone releasing hormone | Predicted secreted proteins
| | | | | Tissue enhanced |
GLYCTK | Glycerate kinase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
GNG13 | Guanine nucleotide binding protein (G protein), gamma 13 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
GPR112 | G protein-coupled receptor 112 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |